Market research

Animal Health

Explore licenses

From the research team

360iResearch introduction

Animal Health: Executive Summary

Animal health encompasses veterinary pharmaceuticals, vaccines, diagnostics, biologics, nutritional products, and services supporting companion animals, livestock, aquaculture, and wildlife. Its importance extends beyond animal welfare: prevention and early detection help protect food safety, agricultural productivity, public health, and the livelihoods that depend on animals. The sector is being reshaped by antimicrobial-resistance concerns, emerging infectious diseases, changing ownership patterns, tighter product oversight, and demand for more preventive and data-enabled care.

Prevention, One Health, and Digital Care Are Reshaping the Sector

The landscape is shifting from treatment-led intervention toward prevention, surveillance, vaccination, biosecurity, and population health management. One Health frameworks increasingly connect veterinary, human-health, environmental, and food-system stakeholders, particularly in response to zoonotic disease and antimicrobial resistance. At the same time, telemedicine, connected monitoring, electronic records, rapid diagnostics, and precision nutrition are changing how clinicians and producers identify risk and manage care. Regulatory scrutiny, traceability expectations, sustainability objectives, and the need for resilient supply chains are reinforcing these changes.

Artificial Intelligence Strengthens Detection, Decision Support, and Operations

Artificial intelligence is contributing to animal health through image interpretation, clinical decision support, outbreak detection, laboratory workflow analysis, herd monitoring, and individualized treatment planning. Machine-learning systems can help identify behavioral, respiratory, mobility, or production changes earlier when trained on representative, high-quality data. However, practical value depends on validation across species and production settings, interoperability with veterinary records and sensors, explainability, cybersecurity, and appropriate professional oversight. AI should therefore augment-not replace-licensed clinical judgment and established animal-welfare safeguards.

Regional Insights: Uneven Infrastructure, Shared One Health Priorities

North America combines advanced veterinary infrastructure with strong demand for companion-animal care, livestock biosecurity, diagnostics, and digital services. Latin America is shaped by large agricultural systems, export requirements, vaccination needs, and uneven access to veterinary resources. Europe emphasizes antimicrobial stewardship, traceability, welfare, and regulatory harmonization. The Middle East faces heat stress, water constraints, transboundary disease risks, and growing demand for specialized services. Africa’s priorities include affordable prevention, veterinary workforce capacity, livestock resilience, and surveillance. Asia-Pacific spans highly diverse markets, with intensive production, aquaculture, companion-animal ownership, and public-health preparedness all influencing adoption patterns.

Group Insights: Cooperation Shapes Standards, Resilience, and Access

ASEAN cooperation is relevant to cross-border livestock movement, food safety, disease surveillance, and capacity building across diverse production systems. BRICS members bring substantial agricultural, veterinary, and research capabilities while also facing varied regulatory and infrastructure conditions. The European Union supports coordinated standards, antimicrobial stewardship, traceability, and animal-welfare objectives. G7 priorities include pandemic preparedness, research collaboration, responsible innovation, and resilient supply chains. GCC countries must address arid-climate pressures, imported food systems, and specialized animal-care needs. NATO members contribute to broader biosecurity, emergency preparedness, and critical-infrastructure resilience discussions, although animal-health implementation remains primarily a civilian and national responsibility.

Country Insights: Diverse Policy and Production Contexts

Australia combines extensive livestock systems with strong biosecurity and geographically dispersed veterinary needs. Brazil’s major agricultural base heightens the importance of herd health, export compliance, and disease prevention. Canada emphasizes livestock, companion animals, surveillance, and remote access to care. China is advancing veterinary modernization, production biosecurity, diagnostics, and regulatory capacity. France, Germany, Italy, and Spain reflect European priorities around welfare, antimicrobial stewardship, traceability, and companion-animal services. India faces substantial demand for accessible veterinary care, livestock productivity, vaccination, and zoonotic-disease control. Japan and South Korea emphasize aging populations, advanced technology, food safety, and companion-animal care. Mexico’s priorities include livestock health, food production, and cross-border disease management. Russia’s animal-health agenda includes domestic production, surveillance, and veterinary supply resilience. The United Kingdom combines strong regulatory oversight with research, farm biosecurity, and sophisticated companion-animal services. The United States integrates extensive veterinary research, livestock and poultry production, companion-animal care, diagnostics, and emergency preparedness.

Leadership Priorities: Build Prevention, Interoperability, and Trust

Industry leaders should prioritize prevention portfolios that address vaccination, biosecurity, diagnostics, antimicrobial stewardship, and welfare outcomes rather than relying solely on late-stage treatment. They should design products and services for different levels of infrastructure, including low-connectivity environments and resource-constrained veterinary systems. Interoperable data standards, transparent evidence generation, strong post-market surveillance, and privacy-conscious AI governance can improve adoption and trust. Partnerships with regulators, veterinarians, producers, laboratories, public-health agencies, and local communities are essential for One Health implementation. Supply-chain diversification, regional manufacturing options, workforce training, and measurable access goals can strengthen resilience and broaden responsible use.

Research Methodology: Evidence-Based Synthesis of Animal-Health Dynamics

This executive summary uses a structured qualitative synthesis of established animal-health themes, including veterinary care, livestock and aquaculture production, companion-animal services, diagnostics, vaccines, biologics, nutrition, regulation, antimicrobial resistance, One Health, digitalization, and artificial intelligence. Findings are organized across the required regions, country groups, and countries to identify recurring policy, infrastructure, epidemiological, and adoption factors. The analysis intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Interpretations should be validated against current national regulations, disease-control programs, peer-reviewed evidence, and local veterinary practice before operational decisions are made.

Conclusion: Prevention and Responsible Innovation Define the Next Phase

Animal health is becoming a more integrated component of food-system resilience, public-health protection, animal welfare, and environmental stewardship. The strongest strategic opportunities arise where prevention, diagnostics, biosecurity, responsible antimicrobial use, and data-enabled care reinforce one another. Regional and national differences require adaptable implementation rather than a single global model. Leaders that combine scientific validation, regulatory alignment, workforce capability, equitable access, and responsible AI governance will be better positioned to deliver durable health outcomes across companion-animal, livestock, aquaculture, and broader One Health settings.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Animal Health Market, by Animal Type
    1. 7.1Introduction
    2. 7.2Companion Animals
      1. 7.2.1Cats
      2. 7.2.2Dogs
    3. 7.3Livestock
      1. 7.3.1Aquaculture
      2. 7.3.2Cattle
      3. 7.3.3Poultry
      4. 7.3.4Swine
  8. 8.Animal Health Market, by Product
    1. 8.1Introduction
    2. 8.2Diagnostics
      1. 8.2.1Immunological Diagnostics
      2. 8.2.2Molecular Diagnostics
    3. 8.3Feed Additives
      1. 8.3.1Enzymes
      2. 8.3.2Prebiotics
      3. 8.3.3Probiotics
    4. 8.4Parasiticides
      1. 8.4.1Ectoparasiticides
      2. 8.4.2Endoparasiticides
    5. 8.5Pharmaceuticals
      1. 8.5.1Branded
      2. 8.5.2Generics
    6. 8.6Vaccines
      1. 8.6.1Killed Inactivated
      2. 8.6.2Live Attenuated
      3. 8.6.3Recombinant
  9. 9.Animal Health Market, by Therapeutic Application
    1. 9.1Introduction
    2. 9.2Anti Infectives
      1. 9.2.1Antibiotics
      2. 9.2.2Antifungals
      3. 9.2.3Antivirals
    3. 9.3Anti Inflammatories
      1. 9.3.1Corticosteroids
      2. 9.3.2NSAIDs
    4. 9.4Antiparasitics
      1. 9.4.1Ectoparasiticides
      2. 9.4.2Endoparasiticides
    5. 9.5Hormonal Therapeutics
      1. 9.5.1Growth Hormones
      2. 9.5.2Reproductive Hormones
  10. 10.Animal Health Market, by Distribution Channel
    1. 10.1Introduction
    2. 10.2Online Stores
      1. 10.2.1Direct To Consumer Websites
      2. 10.2.2Third Party Platforms
    3. 10.3Offline
      1. 10.3.1Chain Pharmacies
      2. 10.3.2Independent Pharmacies
  11. 11.Animal Health Market, by End User
    1. 11.1Introduction
    2. 11.2Animal Owners
      1. 11.2.1Livestock Farmers
      2. 11.2.2Pet Owners
    3. 11.3Feed Manufacturers
    4. 11.4Veterinarians
      1. 11.4.1Large Animal Veterinarians
      2. 11.4.2Mixed Practice Veterinarians
      3. 11.4.3Small Animal Veterinarians
  12. 12.Animal Health Market, by Region
    1. 12.1Introduction
    2. 12.2Asia-Pacific
    3. 12.3Europe
    4. 12.4North America
    5. 12.5Latin America
    6. 12.6Africa
    7. 12.7Middle East
  13. 13.Animal Health Market, by Group
    1. 13.1Introduction
    2. 13.2NATO
    3. 13.3G7
    4. 13.4European Union
    5. 13.5BRICS
    6. 13.6ASEAN
    7. 13.7GCC
  14. 14.Animal Health Market, by Country
    1. 14.1Introduction
    2. 14.2United States
    3. 14.3China
    4. 14.4Germany
    5. 14.5Japan
    6. 14.6India
    7. 14.7United Kingdom
    8. 14.8France
    9. 14.9Canada
    10. 14.10Italy
    11. 14.11Australia
    12. 14.12South Korea
    13. 14.13Brazil
    14. 14.14Mexico
    15. 14.15Russia
    16. 14.16Spain
  15. 15.Competitive Landscape
    1. 15.1Market Share Analysis, 2025
    2. 15.2Market Concentration Analysis, 2025
      1. 15.2.1Concentration Ratio (CR)
      2. 15.2.2Herfindahl Hirschman Index (HHI)
    3. 15.3Recent Developments & Impact Analysis, 2025
    4. 15.4Product Portfolio Analysis, 2025
    5. 15.5Benchmarking Analysis, 2025
  16. 16.Company Profiles
    1. 16.1Alivira Animal Health Limited
    2. 16.2Alltech, Inc.
    3. 16.3Anivive Lifesciences, Inc.
    4. 16.4Boehringer Ingelheim International GmbH
    5. 16.5Bova Holdings Limited by Vimian Group
    6. 16.6Cargill, Incorporated
    7. 16.7Ceva Santé Animale SA
    8. 16.8Chr. Hansen Holding A/S
    9. 16.9Colorado Serum Company
    10. 16.10Covetrus, Inc.
    11. 16.11Dechra Pharmaceuticals PLC
    12. 16.12Dorwest Herbs Ltd.
    13. 16.13Dômes Pharma Group
    14. 16.14Elanco Animal Health Incorporated
    15. 16.15Heska Corporation
    16. 16.16HIPRA, S.A.
    17. 16.17Huvepharma AD
    18. 16.18IDEXX Laboratories, Inc.
    19. 16.19INVETRO Animal Health Pty Ltd
    20. 16.20Kemin Industries, Inc.
    21. 16.21knoell Animal Health Ltd.
    22. 16.22Koninklijke DSM N.V.
    23. 16.23Mars, Incorporated
    24. 16.24Medfiles Group
    25. 16.25Merck & Co., Inc.
    26. 16.26Neogen Corporation
    27. 16.27Phibro Animal Health Corporation
    28. 16.28Vetoquinol S.A.
    29. 16.29Virbac S.A.
    30. 16.30Zoetis Inc.
  17. 17.Key Experts

Loading the sample request form…